In NAFLD and NASH patients, glucose-induced GLP-1 secretion was significantly decreased when compared with controls, thus suggesting that reduced GLP-1 secretion is involved in NAFLD pathophysiology [47]. This evidence concerns the gene GCG and metabolic dysfunction-associated steatotic liver disease.